Canon Medical Accelerates Development of Next-Generation Photon-Counting CT

Canon Medical is accelerating clinical research both domestically and internationally to promote the practical application of Photon Counting CT (PCCT).

Canon Medical initiated joint research on PCCT with the National Cancer Center Exploratory Oncology Research & Clinical Trial Center and East Hospital in April this year to collect and verify a wide range of clinical evidence.

In November this year, Canon Medical entered into agreements with Radboud University Medical Center (RadboudUMC) in the Netherlands and Hiroshima University to further accelerate global research into PCCT. Professor Mathias Prokop, Chairman of the Department of Medical Imaging at RadboudUMC, will lead the research to assess the clinical value of PCCT as a new diagnostic imaging modality. Professor Kazuo Awai of Hiroshima University School of Medicine will also lead research to investigate and evaluate the clinical application of PCCT.

Canon Medical will actively engage in joint research with medical institutions around the world to accelerate the development and clinical application of innovative next-generation PCCT, and will start clinical evaluation in early 2024.

Through these valuable partnerships, we are able to directly receive the opinions and suggestions of leading medical experts who are actually using PCCT. By producing PCCT systems incorporating advanced technologies developed by Canon and promoting their clinical use in all parts of the world, we hope to contribute to the further development of diagnostic imaging technology and achieve the No. 1 share of the global CT market,” said Toshio Takiguchi, President and CEO of Canon Medical Systems Corporation.

To view the source version, please click HERE.

en_GBEnglish (UK)